M Imazio

Summary

Country: Italy

Publications

  1. ncbi Clinical management of acute pericardial disease: a review of results and outcomes
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, ASL 3 Turin, Italy
    Ital Heart J 5:803-17. 2004
  2. ncbi Infective endocarditis in drug addicts: role of HIV infection and the diagnostic accuracy of Duke criteria
    Enrico Cecchi
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    J Cardiovasc Med (Hagerstown) 8:169-75. 2007
  3. ncbi Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, Turin, Italy
    Circulation 124:2290-5. 2011
  4. ncbi Diagnosis and management of pericardial diseases
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Nat Rev Cardiol 6:743-51. 2009
  5. ncbi Individualized therapy for pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy
    Expert Rev Cardiovasc Ther 7:965-75. 2009
  6. ncbi Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention
    Massimo Imazio
    Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Am J Cardiol 103:1525-9. 2009
  7. ncbi Aetiological diagnosis in acute and recurrent pericarditis: when and how
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    J Cardiovasc Med (Hagerstown) 10:217-30. 2009
  8. ncbi Colchicine for pericarditis: hype or hope?
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Eur Heart J 30:532-9. 2009
  9. ncbi [Treatment of acute and recurrent pericarditis. What the clinical cardiologist should know]
    Massimo Imazio
    Dipartimento di Cardiologia, Ospedale Maria Vittoria, Torino
    G Ital Cardiol (Rome) 9:826-34. 2008
  10. ncbi Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance
    Massimo Imazio
    Cardiology Department, Ospedale Maria Vittoria, Torino, Italy
    Int J Cardiol 136:289-93. 2009

Detail Information

Publications63

  1. ncbi Clinical management of acute pericardial disease: a review of results and outcomes
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, ASL 3 Turin, Italy
    Ital Heart J 5:803-17. 2004
    ..Treatment should focus on symptomatic relief, usually through the administration of non-steroidal anti-inflammatory drugs, and patients should be carefully evaluated and monitored for common complications of the disease...
  2. ncbi Infective endocarditis in drug addicts: role of HIV infection and the diagnostic accuracy of Duke criteria
    Enrico Cecchi
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    J Cardiovasc Med (Hagerstown) 8:169-75. 2007
    ..Few data have been reported on the diagnostic accuracy of Duke criteria in IVDUs with or without HIV infection, and a comparison of these two populations is lacking...
  3. ncbi Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, Turin, Italy
    Circulation 124:2290-5. 2011
    ..The aim of the Colchicine for the Prevention of the Post-Pericardiotomy Syndrome (COPPS) POAF substudy was to test the efficacy and safety of colchicine for the prevention of POAF after cardiac surgery...
  4. ncbi Diagnosis and management of pericardial diseases
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Nat Rev Cardiol 6:743-51. 2009
    ..Emerging data indicate that management can be tailored to the individual patient and, although the optimal duration of treatment is not clearly established, some recommendations can be formulated to guide management and follow-up...
  5. ncbi Individualized therapy for pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy
    Expert Rev Cardiovasc Ther 7:965-75. 2009
    ..Corticosteroid use should be restricted, and low-to-medium doses (i.e., prednisone 0.2-0.5 mg/kg/day) should be preferred. Colchicine 0.5-1.2 mg/day is effective for reducing recurrences...
  6. ncbi Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention
    Massimo Imazio
    Surgery, Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Am J Cardiol 103:1525-9. 2009
    ..Early post-AMI pericarditis remains a marker of larger infarct size but without independent prognostic significance...
  7. ncbi Aetiological diagnosis in acute and recurrent pericarditis: when and how
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    J Cardiovasc Med (Hagerstown) 10:217-30. 2009
    ..In developed countries the clinicians should rule out neoplastic, tuberculous, and purulent pericarditis, as well as pericarditis related to a systemic disease...
  8. ncbi Colchicine for pericarditis: hype or hope?
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Eur Heart J 30:532-9. 2009
    ..This paper also reviews specific dosing and precautions for the clinical use...
  9. ncbi [Treatment of acute and recurrent pericarditis. What the clinical cardiologist should know]
    Massimo Imazio
    Dipartimento di Cardiologia, Ospedale Maria Vittoria, Torino
    G Ital Cardiol (Rome) 9:826-34. 2008
    ..The prognosis is good in these cases and the risk of constriction is related to the presence of a specific etiology and not to the number of recurrences...
  10. ncbi Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance
    Massimo Imazio
    Cardiology Department, Ospedale Maria Vittoria, Torino, Italy
    Int J Cardiol 136:289-93. 2009
    ..This study is sought to investigate the prevalence and clinical significance of ANA in IRP...
  11. ncbi Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy
    Circulation 118:667-71. 2008
    ..The aim of this work was to compare side effects, recurrences and other complications, and hospitalizations of a low- versus high-dose regimen of prednisone for recurrent pericarditis...
  12. ncbi Myopericarditis: Etiology, management, and prognosis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy
    Int J Cardiol 127:17-26. 2008
    ..Unfortunately, few data have been published on myopericarditis, the paper reviews current available evidence on the presentation, management, and prognosis of myopericarditis...
  13. ncbi Rationale and design of the COPPS trial: a randomised, placebo-controlled, multicentre study on the use of colchicine for the primary prevention of postpericardiotomy syndrome
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    J Cardiovasc Med (Hagerstown) 8:1044-8. 2007
    ..A preliminary clinical trial has shown that colchicine may be considered not only for the treatment of postpericardiotomy syndrome (PPS), but also for its primary prevention...
  14. ncbi Management of heart failure in elderly people
    M Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Int J Clin Pract 62:270-80. 2008
    ..To review currently available knowledge on presentation, clinical features and management of heart failure (HF) in elderly people...
  15. ncbi CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials--two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study des
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    J Cardiovasc Med (Hagerstown) 8:830-4. 2007
    ..Moreover, some authors recommend the use of the drug at the first recurrence, whereas others propose to consider the drug only after failure of conventional therapies for the second or subsequent recurrence...
  16. ncbi Management of pericardial diseases during pregnancy
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    J Cardiovasc Med (Hagerstown) 11:557-62. 2010
    ..Colchicine is generally contraindicated during pregnancy, except in women with familial Mediterranean fever. These pregnancies should be followed by a dedicated multidisciplinary teams...
  17. ncbi Diagnostic issues in the clinical management of pericarditis
    M Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Int J Clin Pract 64:1384-92. 2010
    ..To review the current major diagnostic issues on the diagnosis of acute and recurrent pericarditis...
  18. ncbi Evaluation and management of pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Expert Rev Cardiovasc Ther 9:1221-33. 2011
    ..e., pregnancy and systemic autoimmune diseases). Recurrences are the most common complication, but the overall prognosis is related to the etiology, usually benign in idiopathic pericarditis...
  19. ncbi Colchicine prevents early postoperative pericardial and pleural effusions
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Am Heart J 162:527-32.e1. 2011
    ..On this basis, we realized a substudy of the COPPS trial to assess the efficacy and safety of colchicine for the prevention of postoperative pericardial and pleural effusions...
  20. ncbi Colchicine treatment for recurrent pericarditis (CORP): a randomized trial
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Ann Intern Med 155:I28. 2011
    ..Recurrence is the most common complication of pericarditis,affecting 10% to 50% of patients...
  21. ncbi Colchicine for recurrent pericarditis (CORP): a randomized trial
    Massimo Imazio
    Maria Vittoria Hospital and Ospedale degli Infermi, Torino, Ospedali Riuniti, Bergamo, San Maurizio Regional Hospital, Bolzano, Italy
    Ann Intern Med 155:409-14. 2011
    ..Recurrence is the most common complication of pericarditis, affecting 10% to 50% of patients. Objective: To evaluate the efficacy and safety of colchicine for the secondary prevention of recurrent pericarditis...
  22. ncbi Risk of constrictive pericarditis after acute pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Circulation 124:1270-5. 2011
    ..The aim of this study is to evaluate the risk of CP after acute pericarditis in a prospective cohort study with long-term follow-up...
  23. ncbi Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Am J Cardiol 108:1183-7. 2011
    ..Severe complications are rare, but the syndrome is responsible for hospital stay prolongation and readmissions. Female gender and pleura incision are risk factors for PPS...
  24. ncbi Pericarditis: pathophysiology, diagnosis, and management
    Massimo Imazio
    Cardiology Department Maria Vittoria Hospital, Via Cibrario 72, 10141, Torino, Italy
    Curr Infect Dis Rep 13:308-16. 2011
    ..The management of pericardial diseases is largely empiric because of the relative lack of randomized trials. NSAIDs are the mainstay of empiric anti-inflammatory therapy, with the possible addition of colchicine to prevent recurrences...
  25. ncbi Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy
    Circulation 123:1092-7. 2011
    ....
  26. ncbi Medical therapy of pericardial diseases: part II: Noninfectious pericarditis, pericardial effusion and constrictive pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    J Cardiovasc Med (Hagerstown) 11:785-94. 2010
    ..In this article, the therapy of more common forms of noninfectious pericarditis (pericarditis in systemic autoimmune diseases and neoplastic pericardial disease), pericardial effusion, and constrictive pericarditis is reviewed...
  27. ncbi Triage and management of pericardial effusion
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, Turin, Italy
    J Cardiovasc Med (Hagerstown) 11:928-35. 2010
    ..e. pericardial window) should be considered whenever fluid re-accumulates (especially with tamponade), becomes loculated, or biopsy material is required...
  28. ncbi COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial
    Massimo Imazio
    Department of Cardiology, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy
    Eur Heart J 31:2749-54. 2010
    ..The aim of the COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS) trial is to test the efficacy and safety of colchicine for the primary prevention of the PPS...
  29. ncbi Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    J Cardiovasc Med (Hagerstown) 11:712-22. 2010
    ..In this article, the therapy of idiopathic and more common forms of infectious pericarditis (viral and bacterial) is reviewed...
  30. ncbi Prognosis of idiopathic recurrent pericarditis as determined from previously published reports
    Massimo Imazio
    Cardiology Department, Ospedale Maria Vittoria, Torino, Italy
    Am J Cardiol 100:1026-8. 2007
    ..Therapeutic choices should take into account of the overall good outcome of these patients, including less toxic agents...
  31. ncbi Treatment of refractory recurrent pericarditis
    Massimo Imazio
    Cardiology Department Maria Vittoria Hospital, Via Cibrario 72, 10141 Turin, Italy
    J Cardiovasc Med (Hagerstown) 8:748-53. 2007
    ..Immunosuppressive drugs and steroid sparing agents might be used, but it should be acknowledged that only weak evidence-based data support their use...
  32. ncbi Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, University of Turin, Turin, Italy
    Circulation 112:2012-6. 2005
    ..The aim of this work was to verify the safety and efficacy of colchicine as an adjunct to conventional therapy for the treatment of the first episode of acute pericarditis...
  33. ncbi [Current perspectives in the management of recurrent pericarditis]
    Massimo Imazio
    Dipartimento di Cardiologia, Ospedale Maria Vittoria, Torino
    Recenti Prog Med 98:265-70. 2007
    ..0% vs 50.6%, p=0.022; NNT= 4.0). No serious adverse effects were observed, while corticosteroids were an independent risk factor for further recurrences (OR 2.89)...
  34. ncbi Myopericarditis versus viral or idiopathic acute pericarditis
    M Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy
    Heart 94:498-501. 2008
    ..To investigate the relative incidence, clinical presentation and prognosis of myopericarditis among patients with idiopathic or viral acute pericarditis...
  35. ncbi Pathogenesis, management, and prevention of recurrent pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    J Cardiovasc Med (Hagerstown) 8:404-10. 2007
    ..In order to provide an evidence-based clinical approach to management, we performed a systematic review of all publications on acute and recurrent pericarditis focusing on recent clinical trials...
  36. ncbi Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndrome
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Am J Cardiol 108:575-9. 2011
    ..Nevertheless, available data suggest a beneficial profile for colchicine and open a new therapeutic strategy for prevention of PPS...
  37. ncbi Indicators of poor prognosis of acute pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, 10141 Torino, Italy
    Circulation 115:2739-44. 2007
    ..The aim of the present article is to assess the relationship between clinical features at presentation and specific causes or complications...
  38. ncbi Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Arch Intern Med 165:1987-91. 2005
    ....
  39. ncbi Triage and management of acute pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Int J Cardiol 118:286-94. 2007
    ..Invasive procedures should be limited mainly to patients in whom therapeutic intervention is necessary...
  40. ncbi Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design amd ratio
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    J Cardiovasc Med (Hagerstown) 8:613-7. 2007
    ..However, the use of the drug is not based on any strong evidence obtained from clinical trials, and no randomized placebo-controlled trial is available to guide the management of acute pericarditis...
  41. ncbi Management, risk factors, and outcomes in recurrent pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Am J Cardiol 96:736-9. 2005
    ..46 to 23.99, p <0.001) was associated with an increased risk for recurrence. After a mean follow-up of 72 months (range 48 to 108), a similar rate of complications was found in patients with or without recurrences...
  42. ncbi Day-hospital treatment of acute pericarditis: a management program for outpatient therapy
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Corso Trapani 195 A, 10141 Turin, Italy
    J Am Coll Cardiol 43:1042-6. 2004
    ..We sought to investigate the safety and efficacy of a protocol for acute pericarditis triage and outpatient management of low-risk cases...
  43. ncbi Relation of acute pericardial disease to malignancy
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    Am J Cardiol 95:1393-4. 2005
    ..0), a lack of response to nonsteroidal anti-inflammatory drugs, and recurrent or incessant pericarditis (OR 10.0). A similar prognosis was found in patients with or without a history of known cancer...
  44. ncbi Cardiac troponin I in acute pericarditis
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    J Am Coll Cardiol 42:2144-8. 2003
    ..This study was designed to investigate the prognostic value of cardiac troponin I (cTnI) in viral or idiopathic pericarditis...
  45. ncbi Omega-3 polyunsatured fatty acids role in postmyocardial infarction therapy
    M Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Panminerva Med 45:99-107. 2003
    ..Mainly on the basis of GISSI Prevention trial results, dietary supplementation with omega-3 PUFA is now recommended as a new component of secondary prevention after myocardial infarction in national and international guidelines...
  46. ncbi Recurrent pain without objective evidence of disease in patients with previous idiopathic or viral acute pericarditis
    Massimo Imazio
    Department of Cardiology, Maria Vittoria Hospital, Torino, Italy
    Am J Cardiol 94:973-5. 2004
    ..After a mean follow-up of 40 months, a higher recurrence rate was recorded in these patients (33.3% vs 14.1%; p = 0.02) as well as a nonsignificant trend to a higher rate of constrictive pericarditis...
  47. ncbi GH-independent cardiotropic activities of hexarelin in patients with severe left ventricular dysfunction due to dilated and ischemic cardiomyopathy
    M Imazio
    Division of Cardiology, University Internal Medicine Department, Turin, Italy
    Eur J Heart Fail 4:185-91. 2002
    ..A possible explanation of the positive inotropic effect of hexarelin in iCMP could be a direct stimulation on viable myocardium or myocardial contractile reserve...
  48. ncbi [Surgical treatment of atrial thrombosis. A transesophageal echocardiogram study]
    M Imazio
    Dipartimento di Medicina Interna, Divisione Universitaria di Cardiologia, , Turin, Italy
    Minerva Cardioangiol 49:279-83. 2001
    ..Unsuccessful medical therapy, a new episode of thrombosis, intracardiac permanent catheter infections and high risk of systemic and pulmonary embolism are indications for thrombectomy...
  49. ncbi Brugada syndrome: a case report of an unusual association with vasospastic angina and coronary myocardial bridging
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Pacing Clin Electrophysiol 25:513-5. 2002
    ..The described association can be important because interaction between ischemia and Brugada syndrome electrophysiological substrate could modulate individual susceptibility to life-threatening ventricular tachyarrhythmias...
  50. ncbi Are the Duke criteria really useful for the early bedside diagnosis of infective endocarditis? Results of a prospective multicenter trial
    Enrico Cecchi
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Ital Heart J 6:41-8. 2005
    ....
  51. ncbi [Does reluctance to perform mouth-to-mouth ventilation exist among emergency healthcare providers as first responders?]
    Massimo Giammaria
    Dipartimento di Cardiologia, Ospedale Maria Vittoria, Torino
    Ital Heart J Suppl 6:90-104. 2005
    ..This is also due to reluctance to perform BLS, especially mouth-to-mouth ventilation without barrier devices in victims who are unknown to the rescuer (either layperson or healthcare provider)...
  52. ncbi Infective endocarditis: diagnostic issues and practical clinical approach based on echocardiography
    Enrico Cecchi
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:414-8. 2008
  53. ncbi Main pulmonary artery aneurysm: a case report and review of the literature
    Massimo Imazio
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Ital Heart J 5:232-7. 2004
    ..An early diagnosis allows timely surgical treatment. We report an unusual case of a main pulmonary artery aneurysm presenting with persistent non-productive cough and provide a review of the pertinent published data...
  54. ncbi A clinical approach for cardiovascular monitoring of HIV-infected patients. Results from an observational cohort study
    Enrico Cecchi
    Cardiology Department, Maria Vittoria Hospital, ASL 3, Turin, Italy
    Ital Heart J 6:972-6. 2005
    ..The aim of this study was to evaluate an alternative clinical approach by which echocardiographic screening is limited to patients with a clinical suspicion of heart disease...
  55. ncbi Infective endocarditis in the real world: the Italian Registry of Infective Endocarditis (Registro Italiano Endocardite Infettiva - RIEI)
    Enrico Cecchi
    Cardiology Department, Maria Vittoria Hospital, Torino, Italy
    J Cardiovasc Med (Hagerstown) 9:508-14. 2008
    ..The background, rationale, aims and expected results of the registry are reviewed...
  56. ncbi New trends in the epidemiological and clinical features of infective endocarditis: results of a multicenter prospective study
    Enrico Cecchi
    Cardiology Department, Maria Vittoria Hospital, Turin, Italy
    Ital Heart J 5:249-56. 2004
    ..We report the results of a 2-year multicenter prospective survey that investigated new trends in the epidemiology, microbiological and clinical features and the prognosis of IE...
  57. ncbi Uncomplicated non-Q wave myocardial infarction: long-term prognosis with a conservative echo-stress guided management strategy
    Enrico Cecchi
    Cardiology Department, Maria Vittoria Hospital, ASL 3, Turin, Italy
    Ital Heart J 3:322-9. 2002
    ....
  58. ncbi Corticosteroid therapy for pericarditis: a double-edged sword
    Massimo Imazio
    Cardiac Rehabilitation Institute, Sheba Medical Center and Sackler University, Tel-Hashomer, Israel
    Nat Clin Pract Cardiovasc Med 5:118-9. 2008
  59. ncbi Colchicine for the prevention of recurrent pericarditis
    Gal Markel
    Sheba Cancer Research Center, Sheba Medical Center, Tel Hashomer, Israel
    Isr Med Assoc J 10:69-72. 2008
    ..The safety profile seems superior to other drugs such as corticosteroids and immunosuppressive drugs...
  60. ncbi Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death
    Alon Eisen
    Cardiac Rehabilitation Institute, Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Circulation 118:1328-34. 2008
    ..The goal of the present study was to assess whether thoracic aorta calcification is associated with an increased risk of cardiovascular events and death in patients with stable angina pectoris...
  61. ncbi Management strategies in pericardial emergencies
    Petar M Seferovic
    Department of Cardiology, Institute for Cardiovascular Disease, Clinical Center of Serbia, Belgrade, Serbia
    Herz 31:891-900. 2006
    ..This condition should immediately lead to cardiac surgery. Although pericardiectomy is the only treatment for permanent constriction, this procedure is contraindicated when extensive myocardial fibrosis and/or atrophy are demonstrated...
  62. ncbi Colchicine for the prevention of the postpericardiotomy syndrome: the COPPS trial
    Massimo Imazio
    Int J Cardiol 121:198-9. 2007
    ..The study will be the first large randomized placebo-controlled trial in this area, and will provide important evidence regarding the possible benefit of colchicine for the primary prevention of the PPS...
  63. ncbi An uncommon cause of acute pericardial disease. The changing aetiology of traumatic pericardial disease
    Enrico Cecchi
    J Cardiovasc Med (Hagerstown) 7:222-3. 2006